Table 3.
Natural Products Treats AR by Interfering with the MAPK Signalling Pathway
| Natural Products | Causality | Subjects | Dose | Mechanisms of Action | References |
|---|---|---|---|---|---|
| Bergapten | Furanocoumarins | BALB/c mice | 10mg/kg/d, 30mg/kg/d | IL-6↓, IL-1β↓, IgE↓, IgG1 ↓, STAT3↓, MAPK↓, IL-12↑, INF-γ↑, IL-4↓, IL-5↓, IL-13↓ | [112] |
| Chlorogenic acid | Phenylpropanoid | BALB/c mice, RAW264.7 cell | 15mgkg/d | NO↓, TNF-α↓, IL-6↓, Tlr4↓, p-p38MAPK↓, p-p65NF-κB↓, p-IκB↓, | [113] |
| Hyperforin | Flavonol glycosides | Human nasal epithelial cells(HNEpCs) | 0.1μM/d, 1μM/d, 10μM/d | p38 MAPK/CCL11↓ | [114] |
| Paeoniflorin | Monoterpene bicyclic glycosides | BALB/c mice | 10mg/kg/d, 20mg/kg/d | p38 MAPK↓, IL-1β↓, TNF-α↓, caspase-1↓, Histamine↓ | [115] |
| Ursolic acid | Triterpenoids | BALB/c mice | 150mg/mL/d, 300mg/mL/d | MAPK↓, ERK↓, IL-17↓, IL-33↓, TNF-α↓ | [116] |
| Asarum sieboldii Miq. essential oil extract | Methyl eugenol | BALB/c mice | 20μM/d | TNF-α↓, IL-4↓, IL-13↓, ROS↓, claudin-1↓, occludin↓, mitochondria↓, eosinophil↓, neutrophil↓, macrophage↓ | [117] |
| Capsaicin | Capsaicinoids | BALB/c mice | 25μg/mL/d, 50μg/mL/d, 75μg/mL/d, 100μg/mL/d | IL-6↓, TNF-α↓, NO↓, EPK1/2↓, p65↓, macrophage↓ | [118] |
| (2′S,7′S)-O-(2-methylbutanoyl)-columbianetin | Flavonoids | HMC-1 cell, BALB/c mice | 10μg/mL/d | L-1β↓, IL-6↓, IL-8↓, TNF-α↓, ERK↓, JNK↓, p38MAPK↓, IκB-α↓, NF-κB↓, Histamine↓, caspase-1↓, MIP-2↓, ICAM-1↓, IFN-γ↑ | [119] |
Notes: ↑ represents upregulation, ↓ represents downregulation.